Description |
chondrolectin |
secretoglobin family 1D member 1 |
Image |
No pdb structure |
No pdb structure |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs) ( 23648065)
- Amyotrophic lateral sclerosis (sporadic) ( 24529757)
- Bulimia nervosa ( 23568457)
- Neuroblastoma or malignant cutaneous melanoma ( 31605138)
- Perceived unattractiveness to mosquitoes ( 28199695)
|
- Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid) ( 24823311)
- Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid) ( 24823311)
- Waist-to-hip ratio adjusted for BMI ( 26426971)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
|
Interacting Genes |
10 interacting genes:
BCL2L2
BNIP2
C2CD2L
CXCL9
DOLK
EBP
IGFBP5
NINJ2
SCGB1D1
ZDHHC21
|
7 interacting genes:
CHODL
CREB3L1
FAM209A
FFAR2
OPRM1
SCGB2A1
SLC38A1
|
Entrez ID |
140578 |
10648 |
HPRD ID |
06261 |
18025 |
Ensembl ID |
ENSG00000154645
|
ENSG00000168515
|
Uniprot IDs |
A0A0C4DFS2
Q9H9P2
|
O95968
|
PDB IDs |
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|